1. Decision Resources. A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe. www.decisionresources.com, 19 Jan 2009 Media Release
2. Bristol-Myers Squibb Company. Bristol-Myers Squibb Completes Acquisition of Medarex, Inc. www.bms.com, 02 Sep 2009 Media Release
3. Bristol-Myers Squibb Company, Medarex Inc. Bristol-Myers Squibb and Medarex Global Development and Commercialization Collaboration for MDX-010 Becomes Effective. http://www.medarex.com, 13 Jan 2005 Media Release
4. Cell Genesys. Cell Genesys Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives. www.cellgenesys.com, 23 Jun 2009 Media Release
5. The Angeles Clinic and Research Institute. The Angeles Clinic and Research Institute Announces Investigational Compound Ipilimumab Demonstrates Improved Overall Survival in Phase 3 Trial of Previously-Treated Patients with Metastatic Melanoma. www.theangelesclinic.org, 06 Jun 2010 Media Release